Work

Real-world outcomes of maintenance olaparib in homologous recombination deficient, BRCA-negative, high-grade ovarian cancer: Insights from clinical practice in Russia.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e17576

Authors: Irina Dudina, Anastasia Danilova, Polina Shilo, Polina Rakhmanova, Ekaterina Runova, Mikhail Volkonsky, Tatiana Kekeeva, Svetlana Kulikova, Svetlana Victorovna Khokhlova, Ilya Pokataev, Ludmila Zhukova, Mikhail Fedyanin, Daniil Stroyakovsky

Institutions: Moscow City Oncology Hospital №62, Research Centre for Medical Genetics, Ministry of Health of the Russian Federation, National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation, Moscow Clinical Scientific Center, Moscow Multidisciplinary Clinical Center "Kommunarka"

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410814885

Cites:

Cited by:

Related to: 10